Deutsche Bank
CTXR icon

Deutsche Bank’s Citius Pharmaceuticals CTXR Stock Holding History

Deutsche Bank’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,457
Closed -$77.8K – 3590
2024
Q1 		$77.8K Hold
3,457
– – ﹤0.01% 3267
2023
Q4 		$65.7K Buy
+3,457
New +$65.6K ﹤0.01% 3382
2022
Q2 		– Sell
-2,463
Closed -$110K – 4161
2022
Q1 		$110K Sell
2,463
-295
-11% -$11.7K ﹤0.01% 3547
2021
Q4 		$106K Buy
2,758
+145
+6% +$6.58K ﹤0.01% 3678
2021
Q3 		$133K Sell
2,613
-84
-3% -$4.21K ﹤0.01% 3764
2021
Q2 		$235K Buy
+2,697
New +$162K ﹤0.01% 3695
2018
Q4 		– Sell
-9
Closed – – 5188
2018
Q3 		$0 Buy
+9
New +$430 ﹤0.01% 5383

Other funds holding CTXR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank's CTXR Position: Q2 2024 in Review

Deutsche Bank sold out of Citius Pharmaceuticals (CTXR) in Q2 2024, closing a stake of 3,457 shares — an estimated $77.8K sold.

Deutsche Bank first reported a position in CTXR in Q3 2018 and held it in 7 quarters. The position peaked at $235K in Q2 2021. 72 funds tracked by Wall St. Rank hold CTXR as of Q2 2024.

  • Deutsche Bank reported no remaining Citius Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 3,457 Citius Pharmaceuticals shares in Q2 2024, an estimated $77.8K.
  • Deutsche Bank first reported a position in Citius Pharmaceuticals in Q3 2018 and held it in 7 quarters.
  • Deutsche Bank's Citius Pharmaceuticals position peaked at $235K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.